Format

Send to

Choose Destination
See comment in PubMed Commons below
J Ayub Med Coll Abbottabad. 2006 Oct-Dec;18(4):4-9.

Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.

Author information

1
Department of Immunology, Medical School, Rafsanjan University of Medical Sciences & Health Services, Rafsanjan, Iran. Jafarzadeh14@yahoo.com

Abstract

BACKGROUND:

Vaccination with the hepatitis B surface antigen (HBsAg) induces protective levels of antibody (anti-HBs = 10 IU/L) in majority of vaccinees. It has been shown that the levels of anti-HBs antibody do wane after vaccination. The aim of this study was to evaluate the persistence of anti-HBs antibodies in healthy Iranian children at 10 years after primary vaccination and the response to a booster dose using recombinant hepatitis B vaccine.

METHODS:

Blood samples were collected from 146 healthy 10-11 years old children who received primary course of Hepatitis B vaccine at 0, 1.5 and 9 months of age. The sera were tested for anti-HBs, antibody to Hepatitis B core antigen (anti-HBc) and HBsAg by ELISA technique. A single booster dose of recombinant hepatitis B vaccine was administered intramuscularly to a total of 94 children, whose anti-HBs antibody was less than 50 IU/L (70 children with anti-HBs < 10 IU/L and 24 subjects with anti-HBs 10-50 IU/L). The sera of children were re-tested for anti-HBs antibody levels at 4 weeks after booster vaccination.

RESULTS:

At 10 years after primary vaccination 70/146 (47.9%) of children had protective levels of antibody with geometric mean titer (GMT) of 68.12 IU/ml. All children were negative for HBsAg, although anti-HBc antibody was positive in 11 (7.5%) of children. In the 94 subjects who received the booster dose the seroprotection and the GMT of anti-HBs antibody were 25.5% and 9.58 IU/L at pre-booster time and rose to 95.75% and 575.6 IU/L after the booster vaccination, respectively. Seroprotection rates and mean titer of antibody similarly expressed in males and females.

CONCLUSION:

The results of present study showed that at 10 years after primary vaccination with recombinant HB vaccine, 47.9% of the children had protective levels of anti-HBs antibody. Moreover we have demonstrated an anamnestic response to booster vaccination that confirms the persistence of an effective immunological memory in vaccinees.

PMID:
17591001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center